<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>59(8)</volume><submitter>Ghamry M</submitter><pubmed_abstract>Rice bran was fermented with &lt;i>Lactobacillus apis,&lt;/i> isolated from the bee gut as a novel probiotic strain, and &lt;i>Saccharomyces cerevisiae&lt;/i> to investigate the relationship between its metabolites and antioxidant activity, nutraceutical value, and cytotoxic activity against the HT-29 cell line. The findings showed that &lt;i>L. apis&lt;/i> improved the antioxidant activity (DPPH of 37.73%) and antioxidant capacity (ABTS of 37.62 mg Trolox/g,), as well as, hydroxyl radical-scavenging activity (91.55%) of rice bran compared to &lt;i>S. cerevisiae.&lt;/i> The metabolic analysis of volatile compounds revealed an increase of alcohols and lactones in the samples fermented with &lt;i>S. cerevisiae&lt;/i>. While the samples fermented with &lt;i>L. apis&lt;/i> displayed an increase of ketones, esters, and thiazoles. On the other hand, &lt;i>L. apis&lt;/i> and &lt;i>S. cerevisiae&lt;/i> exhibited a significant ability to increase γ-aminobutyric acid during different fermentation times. Compared with non-fermented samples (18.54%), &lt;i>L. apis&lt;/i> increased the cytotoxic activity of rice bran against the HT-29 cell line to 34.17%, and &lt;i>S. cerevisiae&lt;/i> to 31.34%. These results suggest that the fermentation of rice bran with &lt;i>S. cerevisiae&lt;/i> and &lt;i>L. apis&lt;/i> provides a promising strategy to improve the antioxidant activity and nutraceuticals of rice bran, and a potential source for plant-based pharmaceutical products.&lt;h4>Supplementary information&lt;/h4>The online version contains supplementary material available at 10.1007/s13197-022-05512-2.</pubmed_abstract><journal>Journal of food science and technology</journal><pagination>3031-3042</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9304478</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Impact of a novel probiotic &lt;i>Lactobacillus&lt;/i> strain isolated from the bee gut on GABA content, antioxidant activity, and potential cytotoxic activity against HT-29 cell line of rice bran.</pubmed_title><pmcid>PMC9304478</pmcid><pubmed_authors>Al-Maqtqri QA</pubmed_authors><pubmed_authors>Ghamry M</pubmed_authors><pubmed_authors>Zhao W</pubmed_authors><pubmed_authors>Ghazal AF</pubmed_authors><pubmed_authors>Li L</pubmed_authors></additional><is_claimable>false</is_claimable><name>Impact of a novel probiotic &lt;i>Lactobacillus&lt;/i> strain isolated from the bee gut on GABA content, antioxidant activity, and potential cytotoxic activity against HT-29 cell line of rice bran.</name><description>Rice bran was fermented with &lt;i>Lactobacillus apis,&lt;/i> isolated from the bee gut as a novel probiotic strain, and &lt;i>Saccharomyces cerevisiae&lt;/i> to investigate the relationship between its metabolites and antioxidant activity, nutraceutical value, and cytotoxic activity against the HT-29 cell line. The findings showed that &lt;i>L. apis&lt;/i> improved the antioxidant activity (DPPH of 37.73%) and antioxidant capacity (ABTS of 37.62 mg Trolox/g,), as well as, hydroxyl radical-scavenging activity (91.55%) of rice bran compared to &lt;i>S. cerevisiae.&lt;/i> The metabolic analysis of volatile compounds revealed an increase of alcohols and lactones in the samples fermented with &lt;i>S. cerevisiae&lt;/i>. While the samples fermented with &lt;i>L. apis&lt;/i> displayed an increase of ketones, esters, and thiazoles. On the other hand, &lt;i>L. apis&lt;/i> and &lt;i>S. cerevisiae&lt;/i> exhibited a significant ability to increase γ-aminobutyric acid during different fermentation times. Compared with non-fermented samples (18.54%), &lt;i>L. apis&lt;/i> increased the cytotoxic activity of rice bran against the HT-29 cell line to 34.17%, and &lt;i>S. cerevisiae&lt;/i> to 31.34%. These results suggest that the fermentation of rice bran with &lt;i>S. cerevisiae&lt;/i> and &lt;i>L. apis&lt;/i> provides a promising strategy to improve the antioxidant activity and nutraceuticals of rice bran, and a potential source for plant-based pharmaceutical products.&lt;h4>Supplementary information&lt;/h4>The online version contains supplementary material available at 10.1007/s13197-022-05512-2.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Aug</publication><modification>2025-04-04T20:07:16.972Z</modification><creation>2025-04-04T20:07:16.972Z</creation></dates><accession>S-EPMC9304478</accession><cross_references><pubmed>35872742</pubmed><doi>10.1007/s13197-022-05512-2</doi></cross_references></HashMap>